Angiogenic Expression Profile of Normal and Neurofibromin-Deficient Human Schwann Cells

被引:0
|
作者
Stacey L. Thomas
George H. De Vries
机构
[1] Edward Hines Jr. V.A. Hospital,Research Service
[2] Loyola University Medical Center,Neuroscience Program
[3] University of Illinois Chicago,Department of Anatomy and Cell Biology
来源
Neurochemical Research | 2007年 / 32卷
关键词
Neurofibromatosis; NF1; Neurofibroma; MPNST; Neurofibromin; Schwann cell; Angiogenesis; Anti-angiogenic; Pro-angiogenic;
D O I
暂无
中图分类号
学科分类号
摘要
Peripheral nerve sheath tumors from individuals with Neurofibromatosis Type 1 (NF1) are highly vascular and contain Schwann cells which are deficient in neurofibromin. This study examines the angiogenic expression profile of neurofibromin-deficient human Schwann cells relative to normal human Schwann cells, characterizing both pro-angiogenic and anti-angiogenic factors. Conditioned media from neurofibromin-deficient Schwann cell lines was pro-angiogenic as evidenced by its ability to stimulate endothelial cell proliferation and migration. Using gene array and protein array analysis, we found increased expression of pro-angiogenic factors and decreased expression of anti-angiogenic factors in neurofibromin-deficient Schwann cells relative to normal human Schwann cells. Neurofibromin-deficient Schwann cells also showed increased expression of several growth factor receptors and decreased expression of an integrin. We conclude that neurofibromin-deficient Schwann cells have dysregulated expression of pro-angiogenic factors, anti-angiogenic factors, growth factor receptors, and an integrin. These dysregulated molecules may contribute to the growth and progression of NF1 peripheral nerve sheath tumors.
引用
收藏
页码:1129 / 1141
页数:12
相关论文
共 50 条
  • [1] Angiogenic expression profile of normal and neurofibromin-deficient human Schwann cells
    Thomas, Stacey L.
    De Vries, George H.
    NEUROCHEMICAL RESEARCH, 2007, 32 (07) : 1129 - 1141
  • [2] Angiogenic expression profile of neurofibromin-deficient Schwann cells and regulation by neurofibromin activity
    Thomas, SL
    De Vries, GH
    JOURNAL OF NEUROCHEMISTRY, 2004, 90 : 6 - 6
  • [3] Angiogenic expression profile of neurofibromin-deficient Schwann cells and regulation by neurofibromin GAP related domain
    De Vries, GH
    Thomas, S
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 50 - 50
  • [4] Tumorigenic properties of neurofibromin-deficient neurofibroma schwann cells
    Muir, D
    Neubauer, D
    Lim, IT
    Yachnis, AT
    Wallace, MR
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (02): : 501 - 513
  • [5] Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with Type 1 Neurofibromatosis
    Ali Badache
    Naser Muja
    George H De Vries
    Oncogene, 1998, 17 : 795 - 800
  • [6] Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis
    Badache, A
    Muja, N
    De Vries, GH
    ONCOGENE, 1998, 17 (06) : 795 - 800
  • [7] Functional MHC Class II Is Upregulated in Neurofibromin-Deficient Schwann Cells
    Reuss, David E.
    Mucha, Jana
    Holtkamp, Nikola
    Mueller, Ute
    Berlien, Hans-Peter
    Mautner, Victor-Felix
    Ehemann, Volker
    Platten, Michael
    Scheffzek, Klaus
    von Deimling, Andreas
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (05) : 1372 - 1375
  • [8] Role of TC/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells
    Huang, Y
    Rangwala, F
    Fulkerson, PC
    Ling, B
    Reed, E
    Cox, AD
    Kamholz, J
    Ratner, N
    ONCOGENE, 2004, 23 (02) : 368 - 378
  • [9] Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells
    Yang, FC
    Ingram, DA
    Chen, S
    Hingtgen, CM
    Ratner, N
    Monk, KR
    Clegg, T
    White, H
    Mead, L
    Wenning, MJ
    Williams, DA
    Kapur, R
    Atkinson, SJ
    Clapp, DW
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (12): : 1851 - 1861
  • [10] Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk
    Staser, Karl
    Park, Su-Jung
    Rhodes, Steven D.
    Zeng, Yi
    He, Yong Zheng
    Shew, Matthew A.
    Gehlhausen, Jeffrey R.
    Cerabona, Donna
    Menon, Keshav
    Chen, Shi
    Sun, Zejin
    Yuan, Jin
    Ingram, David A.
    Nalepa, Grzegorz
    Yang, Feng-Chun
    Clapp, D. Wade
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (01): : 329 - 334